The Board of Directors of Daito Pharmaceutical Co.,Ltd. has authorized a buyback plan on September 14, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,524 JPY | -0.51% | +0.96% | +32.49% |
12/04 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
12/04 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.49% | 251M | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.64% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.